|
|||
|
See also:
Email it to friends
|
Clip Preview:
1: MedGenMed. 2007 Aug 28;9(3):45.
However, COX-2 is a predictive marker for malignant transformation and has a role in the early stages of hepatocarcinogenesis, but not in the advanced stages. The combined expression of both factors in HCV-related HCC suggests their synergistic action in the pathophysiology of hepatocarcinogenesis. |
||